EGF and hepatocellular carcinoma: Among non-Asians with 2 or more low-activity Th1 genotypes, the EGF A/G or G/G genotypes was associated with a borderline statistically significant increased risk of HCC (OR = 2.77, 95% CI = 1.00–7.66, P = 0.049) (Table 4).